551 related articles for article (PubMed ID: 5132825)
1. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
2. [Wilson's disease (hepatolenticular degeneration)].
Bickel H
Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
[No Abstract] [Full Text] [Related]
3. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
Marecek Z; Heyrovský A; Volek V
Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
[TBL] [Abstract][Full Text] [Related]
4. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
5. Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
Arch Neurol; 1971 May; 24(5):391-400. PubMed ID: 5554863
[No Abstract] [Full Text] [Related]
6. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Falkmer S; Samuelson G; Sjölin S
Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
[No Abstract] [Full Text] [Related]
7. Introduction. Symposium on copper metabolism and Wilson's disease.
Goldstein NP; Owen CA
Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
[No Abstract] [Full Text] [Related]
8. [True hepatic Wilson's disease].
Ciravegna B; Giacchino R; Marazzi MG
Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
[TBL] [Abstract][Full Text] [Related]
9. Zinc therapy in Wilson's disease: observations in five patients.
Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
[TBL] [Abstract][Full Text] [Related]
10. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
Gregersen G; Frederiksen G
Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
[No Abstract] [Full Text] [Related]
11. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
[No Abstract] [Full Text] [Related]
12. Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease.
Osborn SB; Szaz KF; Walshe JM
Q J Med; 1969 Oct; 38(152):467-74. PubMed ID: 5355538
[No Abstract] [Full Text] [Related]
13. Iron accumulation in the liver of male patients with Wilson's disease.
Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
[TBL] [Abstract][Full Text] [Related]
14. Glucose intolerance in Wilson's disease. Normalization after treatment with penicillamine.
Johansen K; Gregersen G
Arch Intern Med; 1972 Apr; 129(4):587-90. PubMed ID: 5019448
[No Abstract] [Full Text] [Related]
15. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Germinario L; Campanella G; D'Addabbo A
Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
[No Abstract] [Full Text] [Related]
16. [Penicillamine treatment of Wilson's disease].
Falkmer S; Samuelson G; Sjölin S
Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
[No Abstract] [Full Text] [Related]
17. [Therapeutic considerations on Wilson's disease].
Tavolato B; De Zanche L
G Psichiatr Neuropatol; 1966; 94(4):1085-93. PubMed ID: 5994293
[No Abstract] [Full Text] [Related]
18. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
19. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
20. Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
Osborn SB; Walshe JM
Lancet; 1967 Feb; 1(7486):346-50. PubMed ID: 4163882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
